A Novel, Orally Delivered Antibody Therapy and Its Potential to Prevent Clostridioides difficile Infection in Pre-clinical Models.
Roberts AK, Harris HC, Smith M, Giles J, Polak O, Buckley AM, Clark E, Ewin D, Moura IB, Spitall W, Shone CC, Wilcox M, Chilton C, Donev R.
Roberts AK, et al. Among authors: shone cc.
Front Microbiol. 2020 Sep 22;11:578903. doi: 10.3389/fmicb.2020.578903. eCollection 2020.
Front Microbiol. 2020.
PMID: 33072047
Free PMC article.